| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX)
BCRX Technical Analysis
5
| As on 25th Apr 2025 BCRX STOCK Price closed @ 8.39 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.20 & Strong Buy for SHORT-TERM with Stoploss of 5.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BCRXSTOCK Price
| Open | 8.18 | Change | Price | % |
| High | 8.46 | 1 Day | 0.17 | 2.07 |
| Low | 8.16 | 1 Week | 0.99 | 13.38 |
| Close | 8.39 | 1 Month | 0.85 | 11.27 |
| Volume | 3208207 | 1 Year | 2.32 | 38.22 |
| 52 Week High 9.39 | 52 Week Low 4.13 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| GNLN | 0.01 | -50.00% |
| AGMH | 0.05 | 25.00% |
| OMEX | 1.51 | 77.65% |
| NVDA | 111.01 | 4.30% |
| WW | 0.40 | 166.67% |
| TSLA | 284.95 | 9.80% |
| INTC | 20.05 | -6.70% |
| OPEN | 0.76 | -2.56% |
| LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BCRX Daily Charts |
BCRX Intraday Charts |
Whats New @ Bazaartrend |
BCRX Free Analysis |
|
|
BCRX Important Levels Intraday
| RESISTANCE | 8.97 |
| RESISTANCE | 8.78 |
| RESISTANCE | 8.67 |
| RESISTANCE | 8.55 |
| SUPPORT | 8.23 |
| SUPPORT | 8.11 |
| SUPPORT | 8.00 |
| SUPPORT | 7.81 |
BCRX Forecast April 2025
| 4th UP Forecast | 13.21 |
| 3rd UP Forecast | 11.66 |
| 2nd UP Forecast | 10.71 |
| 1st UP Forecast | 9.75 |
| 1st DOWN Forecast | 7.03 |
| 2nd DOWN Forecast | 6.07 |
| 3rd DOWN Forecast | 5.12 |
| 4th DOWN Forecast | 3.57 |
BCRX Weekly Forecast
| 4th UP Forecast | 11.05 |
| 3rd UP Forecast | 10.20 |
| 2nd UP Forecast | 9.67 |
| 1st UP Forecast | 9.14 |
| 1st DOWN Forecast | 7.64 |
| 2nd DOWN Forecast | 7.11 |
| 3rd DOWN Forecast | 6.58 |
| 4th DOWN Forecast | 5.73 |
BCRX Forecast2025
| 4th UP Forecast | 18.93 |
| 3rd UP Forecast | 15.55 |
| 2nd UP Forecast | 13.46 |
| 1st UP Forecast | 11.37 |
| 1st DOWN Forecast | 5.41 |
| 2nd DOWN Forecast | 3.32 |
| 3rd DOWN Forecast | 1.23 |
| 4th DOWN Forecast | -2.15 |
BioCryst Pharmaceuticals Inc ( NASDAQ USA Symbol : BCRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BCRX Business Profile
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase I clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. BioCryst Pharmaceuticals, Inc. has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. The company was founded in 1986 and is headquartered in Durham, North Carolina. Address: 4505 Emperor Boulevard, Durham, NC, United States, 27703
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service